Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE StudyJOURNAL OF KOREAN MEDICAL SCIENCEIF2.32023-01-0114OAAI
Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility ResidentsEMERGING INFECTIOUS DISEASESIF6.62022-11-0111OAAI
Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022EMERGING INFECTIOUS DISEASESIF6.62022-08-016OAAI
Effectiveness of Booster mRNA Vaccines Against SARS-CoV-2 Infection in an Elderly Population, South Korea, October 2021-January 2022CLINICAL INFECTIOUS DISEASESIF7.32022-04-198OA
Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South KoreaEMERGING INFECTIOUS DISEASESIF6.62022-04-017OAAI
Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021EMERGING INFECTIOUS DISEASESIF6.62022-04-0126OAAI
SARS-CoV-2 Breakthrough Infections after Introduction of 4 COVID-19 Vaccines, South Korea, 2021EMERGING INFECTIOUS DISEASESIF6.62022-03-015OAAI
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021SARS-CoV-2的进口和传输B.1.1.529 (Omicron) 在韩国的关注变体,2021年11月JOURNAL OF KOREAN MEDICAL SCIENCEIF2.32021-01-0176OAAI
Potential antitumor α-methylene-γ-butyrolactone-bearing nucleic acid base.: 3.: Synthesis of 5′-methyl-5′-[(6-substituted-9H-purin-9-yl)methyl]-2′-oxo-3′-methylenetetrahydrofuransARCHIVES OF PHARMACAL RESEARCHIF7.51998-08-012PREAI
Potential antitumor alpha-methylene-gamma-butyrolactone-bearing nucleic acid bases .2. Synthesis of 5'-methyl-5'-[2-(5-substituted uracil-1-yl)ethyl]-2'-oxo-3'-methylenetetrahydrofuransARCHIVES OF PHARMACAL RESEARCHIF7.51997-06-018PREAI
Synthesis and antitumor evaluation of alpha-methylene-gamma-butyrolactone-linked to 5-substituted uracil nucleic acid basesARCHIVES OF PHARMACAL RESEARCHIF7.51996-06-0110PREAI